{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T16:54:16Z","timestamp":1775580856922,"version":"3.50.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["482666\/2012-9"],"award-info":[{"award-number":["482666\/2012-9"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["573799\/2008-3"],"award-info":[{"award-number":["573799\/2008-3"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["08\/57889-1"],"award-info":[{"award-number":["08\/57889-1"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Agents Cancer"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13027-017-0163-4","type":"journal-article","created":{"date-parts":[[2017,10,13]],"date-time":"2017-10-13T07:51:36Z","timestamp":1507881096000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["HPV infection and p53 and p16 expression in esophageal cancer: are they prognostic factors?"],"prefix":"10.1186","volume":"12","author":[{"given":"Allini Mafra","family":"da Costa","sequence":"first","affiliation":[]},{"given":"Jos\u00e9 Humberto Tavares Guerreiro","family":"Fregnani","sequence":"additional","affiliation":[]},{"given":"Paula Roberta Aguiar","family":"Pastrez","sequence":"additional","affiliation":[]},{"given":"V\u00e2nia Sammartino","family":"Mariano","sequence":"additional","affiliation":[]},{"given":"Estela Maria","family":"Silva","sequence":"additional","affiliation":[]},{"given":"Cristovam Scapulatempo","family":"Neto","sequence":"additional","affiliation":[]},{"given":"Denise Peixoto","family":"Guimar\u00e3es","sequence":"additional","affiliation":[]},{"given":"Luisa Lina","family":"Villa","sequence":"additional","affiliation":[]},{"given":"Laura","family":"Sichero","sequence":"additional","affiliation":[]},{"given":"Kari Juhani","family":"Syrjanen","sequence":"additional","affiliation":[]},{"given":"Adhemar","family":"Longatto-Filho","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2017,10,13]]},"reference":[{"key":"163_CR1","unstructured":"GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet] [ http:\/\/globocan.iarc.fr ]. Accessed 27 Sept 2017."},{"key":"163_CR2","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/1751-2980.12236","volume":"16","author":"WL Wang","year":"2015","unstructured":"Wang WL, Wang YC, Lee CT, Chang CY, Lo JL, Kuo YH, Hsu YC, Mo LR. The impact of human papillomavirus infection on the survival and treatment response of patients with esophageal cancers. J Dig Dis. 2015;16:256\u201363.","journal-title":"J Dig Dis"},{"key":"163_CR3","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.3892\/ol.2015.3624","volume":"10","author":"J Chen","year":"2015","unstructured":"Chen J, Wu F, Pei HL, Gu WD, Ning ZH, Shao YJ, Huang J. Analysis of the correlation between P53 and Cox-2 expression and prognosis in esophageal cancer. Oncol Lett. 2015;10:2197\u2013203.","journal-title":"Oncol Lett"},{"key":"163_CR4","volume-title":"Papillomavirus Humains Biologie et pathologie tumorale","author":"K Syrjanen","year":"2003","unstructured":"Syrjanen K. HPV et tumeurs \u00e9pidermo\u00efdes b\u00e9nignes et malignes de l\u2019\u00e6sophag. In: PJ AF, Mougin C, editors. Papillomavirus Humains Biologie et pathologie tumorale. Paris: TEC & DOC; 2003."},{"key":"163_CR5","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1136\/jcp.55.10.721","volume":"55","author":"KJ Syrjanen","year":"2002","unstructured":"Syrjanen KJ. HPV infections and oesophageal cancer. J Clin Pathol. 2002;55:721\u20138.","journal-title":"J Clin Pathol"},{"key":"163_CR6","first-page":"417","volume":"57","author":"KJ Syrjanen","year":"1987","unstructured":"Syrjanen KJ. Human papillomavirus (HPV) infections and their associations with squamous cell neoplasia. Arch Geschwulstforsch. 1987;57:417\u201344.","journal-title":"Arch Geschwulstforsch"},{"key":"163_CR7","first-page":"29","volume-title":"Recent advances in gastroenterological carcinogenesis I","author":"K Syrj\u00e4nen","year":"1996","unstructured":"Syrj\u00e4nen K, Chang F, Syrj\u00e4nen S. Infectious agents as etiological factors in esophageal carcinogenesis. In: Tahara E, Sugimachi K, Oohara T, editors. Recent advances in gastroenterological carcinogenesis I. Bologna: Monduzzi Editore; 1996. p. 29\u201343."},{"key":"163_CR8","first-page":"413","volume-title":"Papillomavirus infections in human pathology","author":"K Syrjanen","year":"2000","unstructured":"Syrjanen K. HPV infections of the oesophagus. In: Papillomavirus infections in human pathology. New York: Wiley & Sons; 2000. p. 413\u201328."},{"key":"163_CR9","first-page":"169","volume-title":"4th International Multidisciplinary Congress EUROGIN (Monsonego J ed. Pp. 169\u2013179)","author":"K Syrjanen","year":"2000","unstructured":"Syrjanen K. HPV infections in etiology of benign and malignant sinonasal, bronchial and oesophageal squamous cell lesions. In: 4th International Multidisciplinary Congress EUROGIN (Monsonego J ed. Pp. 169\u2013179). Bolongna: Monduzzi Editore; 2000. p. 169\u201379."},{"key":"163_CR10","first-page":"291","volume":"5","author":"K Syrjanen","year":"1982","unstructured":"Syrjanen K, Pyrhonen S, Aukee S, Koskela E. Squamous cell papilloma of the esophagus: a tumour probably caused by human papilloma virus (HPV). Diagn Histopathol. 1982;5:291\u20136.","journal-title":"Diagn Histopathol"},{"key":"163_CR11","first-page":"283","volume":"52","author":"KJ Syrjanen","year":"1982","unstructured":"Syrjanen KJ. Histological changes identical to those of condylomatous lesions found in esophageal squamous cell carcinomas. Arch Geschwulstforsch. 1982;52:283\u201392.","journal-title":"Arch Geschwulstforsch"},{"key":"163_CR12","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.gtc.2009.01.004","volume":"38","author":"F Kamangar","year":"2009","unstructured":"Kamangar F, Chow WH, Abnet CC, Dawsey SM. Environmental causes of esophageal cancer. Gastroenterol Clin N Am. 2009;38:27\u201357. vii","journal-title":"Gastroenterol Clin N Am"},{"key":"163_CR13","doi-asserted-by":"crossref","first-page":"6598","DOI":"10.3748\/wjg.v19.i39.6598","volume":"19","author":"LC Antunes","year":"2013","unstructured":"Antunes LC, Prolla JC, de Barros LA, da Rocha MP, Fagundes RB. No evidence of HPV DNA in esophageal squamous cell carcinoma in a population of southern Brazil. World J Gastroenterol. 2013;19:6598\u2013603.","journal-title":"World J Gastroenterol"},{"key":"163_CR14","doi-asserted-by":"crossref","first-page":"e111045","DOI":"10.1371\/journal.pone.0111045","volume":"9","author":"L Shang","year":"2014","unstructured":"Shang L, Liu HJ, Hao JJ, Jiang YY, Shi F, Zhang Y, Cai Y, Xu X, Jia XM, Zhan QM, Wang MR. A panel of overexpressed proteins for prognosis in esophageal squamous cell carcinoma. PLoS One. 2014;9:e111045.","journal-title":"PLoS One"},{"key":"163_CR15","doi-asserted-by":"crossref","first-page":"903","DOI":"10.3892\/ol.2013.1130","volume":"5","author":"S Shibata-Kobayashi","year":"2013","unstructured":"Shibata-Kobayashi S, Yamashita H, Okuma K, Shiraishi K, Igaki H, Ohtomo K, Nakagawa K. Correlation among 16 biological factors [p53, p21(waf1), MIB-1 (Ki-67), p16(INK4A), cyclin D1, E-cadherin, Bcl-2, TNF-alpha, NF-kappaB, TGF-beta, MMP-7, COX-2, EGFR, HER2\/neu, ER, and HIF-1alpha] and clinical outcomes following curative chemoradiation therapy in 10 patients with esophageal squamous cell carcinoma. Oncol Lett. 2013;5:903\u201310.","journal-title":"Oncol Lett"},{"key":"163_CR16","first-page":"7158","volume":"7","author":"W Yao","year":"2014","unstructured":"Yao W, Qin X, Qi B, Lu J, Guo L, Liu F, Liu S, Zhao B. Association of p53 expression with prognosis in patients with esophageal squamous cell carcinoma. Int J Clin Exp Pathol. 2014;7:7158\u201363.","journal-title":"Int J Clin Exp Pathol"},{"key":"163_CR17","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1200\/JCO.1995.13.4.1009","volume":"13","author":"F Chang","year":"1995","unstructured":"Chang F, Syrjanen S, Syrjanen K. Implications of the p53 tumor-suppressor gene in clinical oncology. J Clin Oncol. 1995;13:1009\u201322.","journal-title":"J Clin Oncol"},{"key":"163_CR18","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1200\/JCO.2008.20.2853","volume":"27","author":"P Lassen","year":"2009","unstructured":"Lassen P, Eriksen JG, Hamilton-Dutoit S, Tramm T, Alsner J, Overgaard J. Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck. J Clin Oncol. 2009;27:1992\u20138.","journal-title":"J Clin Oncol"},{"key":"163_CR19","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1200\/JCO.2001.19.8.2272","volume":"19","author":"I Sturm","year":"2001","unstructured":"Sturm I, Petrowsky H, Volz R, Lorenz M, Radetzki S, Hillebrand T, Wolff G, Hauptmann S, Dorken B, Daniel PT. Analysis of p53\/BAX\/p16(ink4a\/CDKN2) in esophageal squamous cell carcinoma: high BAX and p16(ink4a\/CDKN2) identifies patients with good prognosis. J Clin Oncol. 2001;19:2272\u201381.","journal-title":"J Clin Oncol"},{"key":"163_CR20","first-page":"804738","volume":"2014","author":"F Cao","year":"2014","unstructured":"Cao F, Han H, Zhang F, Wang B, Ma W, Wang Y, Sun G, Shi M, Ren Y, Cheng Y. HPV infection in esophageal squamous cell carcinoma and its relationship to the prognosis of patients in northern China. ScientificWorldJournal. 2014;2014:804738.","journal-title":"ScientificWorldJournal"},{"key":"163_CR21","doi-asserted-by":"crossref","first-page":"7161","DOI":"10.7314\/APJCP.2015.16.16.7161","volume":"16","author":"R Kumar","year":"2015","unstructured":"Kumar R, Ghosh SK, Verma AK, Talukdar A, Deka MK, Wagh M, Bahar HM, Tapkire R, Chakraborty KP, Kannan RR. p16 expression as a surrogate marker for HPV infection in esophageal Squamous cell carcinoma can predict response to neo-adjuvant chemotherapy. Asian Pac J Cancer Prev. 2015;16:7161\u20135.","journal-title":"Asian Pac J Cancer Prev"},{"key":"163_CR22","first-page":"3430","volume":"7","author":"F Cao","year":"2014","unstructured":"Cao F, Zhang W, Zhang F, Han H, Xu J, Cheng Y. Prognostic significance of high-risk human papillomavirus and p16(INK4A) in patients with esophageal squamous cell carcinoma. Int J Clin Exp Med. 2014;7:3430\u20138.","journal-title":"Int J Clin Exp Med"},{"key":"163_CR23","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s12032-014-0257-4","volume":"31","author":"XL Xu","year":"2014","unstructured":"Xu XL. Zheng WH, Tao KY, Li XX, Xu WZ, Wang Y, Zhu SM, Mao WM: p53 is an independent prognostic factor in operable esophageal squamous cell carcinoma: a large-scale study with a long follow-up. Med Oncol. 2014;31:257.","journal-title":"Med Oncol"},{"key":"163_CR24","unstructured":"Green MR, Sambrook J. Molecular Cloning: A Laboratory Manual, 4thed. New York: John Inglis N; 2012."},{"key":"163_CR25","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.7150\/jca.17080","volume":"8","author":"PRA Pastrez","year":"2017","unstructured":"Pastrez PRA, Mariano VS, da Costa AM, Silva EM, Scapulatempo-Neto C, Guimaraes DP, Fava G, Neto SAZ, Nunes EM, Sichero L, et al. The relation of HPV infection and expression of p53 and p16 proteins in esophageal Squamous cells carcinoma. J Cancer. 2017;8:1062\u201370.","journal-title":"J Cancer"},{"key":"163_CR26","unstructured":"da Costa AM, Fregnani J, Pastrez PRA, Mariano VS, Neto CS, Guimaraes DP, de Oliveira KMG, Neto SAZ, Nunes EM, Ferreira S, et al. Prevalence of high risk HPV DNA in esophagus is high in Brazil but not related to esophageal squamous cell carcinoma. Histol Histopathol. 2017;11929"},{"key":"163_CR27","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1128\/JCM.44.2.504-512.2006","volume":"44","author":"M Schmitt","year":"2006","unstructured":"Schmitt M, Bravo IG, Snijders PJ, Gissmann L, Pawlita M, Waterboer T. Bead-based multiplex genotyping of human papillomaviruses. J Clin Microbiol. 2006;44:504\u201312.","journal-title":"J Clin Microbiol"},{"key":"163_CR28","unstructured":"World Health Organization. Genital human papillomavirus infections and cancer: memorandum from a WHO meeting. Bull World Health Organ. 1987;65:817\u201327."},{"key":"163_CR29","first-page":"641","volume":"10","author":"ZY Shen","year":"2002","unstructured":"Shen ZY, Xu LY, Li EM, Shen J, Zheng RM, Cai WJ, Zeng Y. Immortal phenotype of the esophageal epithelial cells in the process of immortalization. Int J Mol Med. 2002;10:641\u20136.","journal-title":"Int J Mol Med"},{"key":"163_CR30","first-page":"165","volume":"24","author":"J Cervantes","year":"2004","unstructured":"Cervantes J. Update on the pathogenesis and immunotherapy of esophageal squamous cell carcinoma. Rev Gastroenterol Peru. 2004;24:165\u201370.","journal-title":"Rev Gastroenterol Peru"},{"key":"163_CR31","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.7150\/jca.12346","volume":"6","author":"CJ Tao","year":"2015","unstructured":"Tao CJ, Lin G, Xu YP, Mao WM. Predicting the response of Neoadjuvant therapy for patients with esophageal carcinoma: an in-depth literature review. J Cancer. 2015;6:1179\u201386.","journal-title":"J Cancer"},{"key":"163_CR32","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1200\/JCO.2004.00.3335","volume":"24","author":"PM Weinberger","year":"2006","unstructured":"Weinberger PM, Yu Z, Haffty BG, Kowalski D, Harigopal M, Brandsma J, Sasaki C, Joe J, Camp RL, Rimm DL, Psyrri A. Molecular classification identifies a subset of human papillomavirus--associated oropharyngeal cancers with favorable prognosis. J Clin Oncol. 2006;24:736\u201347.","journal-title":"J Clin Oncol"},{"key":"163_CR33","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/jnci\/djn011","volume":"100","author":"C Fakhry","year":"2008","unstructured":"Fakhry C, Westra WH, Li S, Cmelak A, Ridge JA, Pinto H, Forastiere A, Gillison ML. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst. 2008;100:261\u20139.","journal-title":"J Natl Cancer Inst"},{"key":"163_CR34","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1056\/NEJMoa0912217","volume":"363","author":"KK Ang","year":"2010","unstructured":"Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tan PF, Westra WH, Chung CH, Jordan RC, Lu C, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010;363:24\u201335.","journal-title":"N Engl J Med"},{"key":"163_CR35","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1471-2407-6-94","volume":"6","author":"M Dreilich","year":"2006","unstructured":"Dreilich M, Bergqvist M, Moberg M, Brattstrom D, Gustavsson I, Bergstrom S, Wanders A, Hesselius P, Wagenius G, Gyllensten U. High-risk human papilloma virus (HPV) and survival in patients with esophageal carcinoma: a pilot study. BMC Cancer. 2006;6:94.","journal-title":"BMC Cancer"},{"key":"163_CR36","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1586\/14760584.2016.1124763","volume":"15","author":"SR Skinner","year":"2016","unstructured":"Skinner SR, Apter D, De Carvalho N, Harper DM, Konno R, Paavonen J, Romanowski B, Roteli-Martins C, Burlet N, Mihalyi A, Struyf F. Human papillomavirus (HPV)-16\/18 AS04-adjuvanted vaccine for the prevention of cervical cancer and HPV-related diseases. Expert Rev Vaccines. 2016;15:367\u201387.","journal-title":"Expert Rev Vaccines"},{"key":"163_CR37","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/MEG.0b013e32832c7e76","volume":"22","author":"WK Liu","year":"2010","unstructured":"Liu WK, Jiang XY, Zhang MP, Zhang ZX. The relationship between HPV16 and expression of cyclooxygenase-2, P53 and their prognostic roles in esophageal squamous cell carcinoma. Eur J Gastroenterol Hepatol. 2010;22:67\u201374.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"163_CR38","first-page":"677","volume":"13","author":"M Hippelainen","year":"1993","unstructured":"Hippelainen M, Eskelinen M, Lipponen P, Chang F, Syrjanen K. Mitotic activity index, volume corrected mitotic index and human papilloma-virus suggestive morphology are not prognostic factors in carcinoma of the oesophagus. Anticancer Res. 1993;13:677\u201381.","journal-title":"Anticancer Res"},{"key":"163_CR39","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.canlet.2012.07.018","volume":"326","author":"S Herbster","year":"2012","unstructured":"Herbster S, Ferraro CT, Koff NK, Rossini A, Kruel CD, Andreollo NA, Rapozo DC, Blanco TC, Faria PA, Santos PT, et al. HPV infection in Brazilian patients with esophageal squamous cell carcinoma: interpopulational differences, lack of correlation with surrogate markers and clinicopathological parameters. Cancer Lett. 2012;326:52\u20138.","journal-title":"Cancer Lett"},{"key":"163_CR40","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/ijc.2910540211","volume":"54","author":"M Furihata","year":"1993","unstructured":"Furihata M, Ohtsuki Y, Ogoshi S, Takahashi A, Tamiya T, Ogata T. Prognostic significance of human papillomavirus genomes (type-16, \u221218) and aberrant expression of p53 protein in human esophageal cancer. Int J Cancer. 1993;54:226\u201330.","journal-title":"Int J Cancer"},{"key":"163_CR41","doi-asserted-by":"crossref","first-page":"4958","DOI":"10.3748\/wjg.v16.i39.4958","volume":"16","author":"N Taghavi","year":"2010","unstructured":"Taghavi N, Biramijamal F, Sotoudeh M, Moaven O, Khademi H, Abbaszadegan MR, Malekzadeh R. Association of p53\/p21 expression with cigarette smoking and prognosis in esophageal squamous cell carcinoma patients. World J Gastroenterol. 2010;16:4958\u201367.","journal-title":"World J Gastroenterol"},{"key":"163_CR42","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1440-1827.2005.01804.x","volume":"55","author":"AA Bahnassy","year":"2005","unstructured":"Bahnassy AA, Zekri AR, Abdallah S, El-Shehaby AM, Sherif GM. Human papillomavirus infection in Egyptian esophageal carcinoma: correlation with p53, p21, mdm2, C-erbB2 and impact on survival. Pathol Int. 2005;55:53\u201362.","journal-title":"Pathol Int"},{"key":"163_CR43","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.3892\/ol.2014.2343","volume":"8","author":"K Huang","year":"2014","unstructured":"Huang K, Chen L, Zhang J, Wu Z, Lan L, Wang L, Lu B, Liu Y. Elevated p53 expression levels correlate with tumor progression and poor prognosis in patients exhibiting esophageal squamous cell carcinoma. Oncol Lett. 2014;8:1441\u20136.","journal-title":"Oncol Lett"},{"key":"163_CR44","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1442-2050.2007.00634.x","volume":"20","author":"U Han","year":"2007","unstructured":"Han U, Can OI, Han S, Kayhan B, Onal BU. Expressions of p53, VEGF C, p21: could they be used in preoperative evaluation of lymph node metastasis of esophageal squamous cell carcinoma? Dis Esophagus. 2007;20:379\u201385.","journal-title":"Dis Esophagus"},{"key":"163_CR45","first-page":"2192","volume":"59","author":"B Ye","year":"2012","unstructured":"Ye B, Wang X, Yang Z, Sun Z, Zhang R, Hu Y, Lu Y, Du J. p53 and p73 expression in esophageal carcinoma correlate with clinicopathology of tumors. Hepato-Gastroenterology. 2012;59:2192\u20135.","journal-title":"Hepato-Gastroenterology"},{"key":"163_CR46","first-page":"359","volume":"8","author":"O Chino","year":"2001","unstructured":"Chino O, Kijima H, Shimada H, Nishi T, Tanaka H, Kise Y, Kenmochi T, Himeno S, Machimura T, Tanaka M, et al. Accumulation of p53 in esophageal squamous cell carcinoma. Int J Mol Med. 2001;8:359\u201363.","journal-title":"Int J Mol Med"},{"key":"163_CR47","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1007\/s12032-013-0728-z","volume":"30","author":"A Murata","year":"2013","unstructured":"Murata A, Baba Y, Watanabe M, Shigaki H, Miyake K, Karashima R, Imamura Y, Ida S, Ishimoto T, Iwagami S, et al. p53 immunohistochemical expression and patient prognosis in esophageal squamous cell carcinoma. Med Oncol. 2013;30:728.","journal-title":"Med Oncol"},{"key":"163_CR48","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1016\/j.jtcvs.2014.06.079","volume":"148","author":"D Kandioler","year":"2014","unstructured":"Kandioler D, Schoppmann SF, Zwrtek R, Kappel S, Wolf B, Mittlbock M, Kuhrer I, Hejna M, Pluschnig U, Ba-Ssalamah A, et al. The biomarker TP53 divides patients with neoadjuvantly treated esophageal cancer into 2 subgroups with markedly different outcomes. A p53 research group study. J Thorac Cardiovasc Surg. 2014;148:2280\u20136.","journal-title":"J Thorac Cardiovasc Surg"}],"container-title":["Infectious Agents and Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13027-017-0163-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,4]],"date-time":"2019-10-04T12:55:08Z","timestamp":1570193708000},"score":1,"resource":{"primary":{"URL":"http:\/\/infectagentscancer.biomedcentral.com\/articles\/10.1186\/s13027-017-0163-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,13]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["163"],"URL":"https:\/\/doi.org\/10.1186\/s13027-017-0163-4","relation":{},"ISSN":["1750-9378"],"issn-type":[{"value":"1750-9378","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,13]]},"article-number":"54"}}